Foresite Capital Fund VI, L.P. 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-20 9:00 pm Purchase | 2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI | Foresite Capital Fund VI, L.P. | 1,309,383 9.800% | 1,309,383 (New Position) | Filing |